Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®

Nagaendran Kandiah,Paulus Anam Ong,Turana Yuda,Li Ling Ng,Kaysar Mamun,Reshma A. Merchant,Christopher Chen,Jacqueline C. Dominguez,Simeon Marasigan,Encarnita Ampil,Van Thong Nguyen,Suraya Yusoff,Yee Fai Chan,Fee Mann Yong,Orapitchaya Krairit,Chuthamanee Suthisisang,Vorapun Senanarong,Yong Ji,Ramesh Thukral,Ralf Ihl

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®

2019

Background The Ginkgo biloba special extract, EGb 761® has been widely used in the treatment of neuropsychiatric disorders, including Alzheimer’s disease (AD).

Keywords:

Anesthesia
Alzheimer's disease
Ginkgo biloba
Stroke
Dementia
Cognition
Medicine
Internal medicine
Diabetes mellitus
Vascular dementia
Placebo
Neurocognitive
Biological psychiatry
Memantine
Randomized controlled trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations